Rituximab Use in Adult Primary Glomerulopathy: Where Is the Evidence?

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s114316
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Where Is the Evidence?

Adoption & Fostering
SociologyHuman FactorsHealthPolitical ScienceSocial PsychologyErgonomicsLaw
2004English

Social Prescribing: Where Is the Evidence?

British Journal of General Practice
MedicineFamily Practice
2018English

Cholangiocytes and the Environment in Primary Sclerosing Cholangitis: Where Is the Link?

Gut
Gastroenterology
2017English

Where There Is No Evidence: Use of Expert Consensus Methods to Fill the Evidence Gap in Low-Income Countries and Cultural Minorities

International Journal of Mental Health Systems
Mental HealthEnvironmentalPublic HealthPsychiatric Mental HealthHealth PolicyPsychiatryOccupational Health
2010English

Concurrency Driving the African HIV Epidemics: Where Is the Evidence?

The Lancet
Medicine
2009English

Intra-Arterial Thrombolysis Within 3 Hours: Where Is the Evidence?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Where Transit Use Is Growing: Surprising Results

Journal of Public Transportation
DevelopmentUrban StudiesPlanningTransportationGeography
2006English

Available Evidence and Outcome of Off-Label Use of Rituximab in Clinical Practice

European Journal of Clinical Pharmacology
MedicinePharmacology
2013English

Rituximab Use in Nephrotic Syndrome

Journal of Clinical Review & Case Reports
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy